ICONLOOP.png
ICONLOOP and Shinhan Bank Launch First Blockchain-based Financial KYC Compliance Certification Service in South Korea
August 26, 2020 08:00 ET | ICONLOOP
SEOUL, SOUTH KOREA, Aug. 26, 2020 (GLOBE NEWSWIRE) -- (via Blockchain Wire) - ICONLOOP (www.iconloop.com) today announced a partnership with Shinhan Bank, Korea’s second-largest commercial bank, to...
1560299622569_565f707102c48200096556f0_logo.jpg
BioLargo, BKT, and Tomorrow Water Set to Launch Joint Venture to Manufacture and Distribute CupriDyne Clean Based Products in South Korea
March 18, 2020 10:07 ET | BioLargo, Inc.
Operations commencing soon Westminster, CA, March 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a full-service...
TOMI Environmental Solutions, Inc. Logo
STERAMIST IS MOBILIZED TO AID IN THE CONTROL SARS-CoV-2 IN DAEGU-KYUNGBUK PROVINCE, SOUTH KOREA
March 10, 2020 16:00 ET | TOMI Environmental Solutions, Inc.
BEVERLY HILLS, Calif., March 10, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (OTCQB:TOMZ), is a global company specializing in disinfection and decontamination, utilizing...
Freedom Needed to Combat Coronavirus, States Association of American Physicians and Surgeons (AAPS)
March 10, 2020 15:20 ET | Association of American Physicians and Surgeons
TUCSON, Ariz., March 10, 2020 (GLOBE NEWSWIRE) -- The coronavirus pandemic shows the effect of government interference with free-market solutions, states the Association of American Physicians and...
TOMI Environmental Solutions, Inc. Logo
SteraMist Declared Official Decontamination Technology of Seoul City Metropolitan Transit Systems
March 02, 2020 09:30 ET | TOMI Environmental Solutions, Inc.
BEVERLY HILLS, Calif., March 02, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (OTCQB:TOMZ), is a global company specializing in disinfection and decontamination, utilizing...
Rafael_Pharma-Logo+Slogan.png
Rafael Pharmaceuticals Announces Expansion into South Korea of Pivotal Phase 3 Trial of CPI-613® (devimistat) in Patients with Metastatic Pancreatic Cancer
October 24, 2019 09:00 ET | Rafael Pharmaceuticals, Inc.
Cranbury, NJ, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, today announced that...
BD_Long.png
Busan in South Korea is fast becoming a world-class MICE destination
September 02, 2019 04:30 ET | Business Destinations
LONDON, Sept. 02, 2019 (GLOBE NEWSWIRE) -- Although the bustling South Korean city of Busan may be best known for its attractive beaches, large port and striking temples, it has recently arisen as a...
BD_Long.png
Business Destinations explores overtourism solutions, Peru’s Machu Picchu paradox and the complexities of Tibetan tourism in its latest issue
July 31, 2019 05:00 ET | Business Destinations
LONDON, July 31, 2019 (GLOBE NEWSWIRE) -- All around the world, popular destinations are struggling under the weight of the explosive growth of the global tourism industry. In 2018, 1.4 billion...
JCET - South Korea
New JCET 12 Inch Wafer Bumping Line in Advanced Flip Chip South Korea Factory Ramps into High Volume INCHEON, South Korea, July 29, 2019 (GLOBE NEWSWIRE) -- Jiangsu Changjiang Electronics Technology Co., Ltd. (‘JCET’) has moved into volume production with its new 12 inch wafer bumping line which is...
Rafael_Pharma-Logo+Slogan.png
Rafael Pharmaceuticals Enters into Out-Licensing Agreement with Ono Pharmaceutical to Accelerate Clinical Development and Commercialization of Cancer Drug Candidate CPI-613® (devimistat) in Japan and Other Asian Countries
June 25, 2019 08:00 ET | Rafael Pharmaceutical Inc.
Cranbury, NJ, June 25, 2019 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”), a leader in the growing field of cancer metabolism-based therapeutics, announced today that...